Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Quest planning $1.3B note deal

March 22, 2011 1:02 AM UTC

Quest Diagnostics Inc. (NYSE:DGX) plans to sell $1.3 billion in senior unsecured notes. Morgan Stanley; Goldman Sachs; RBS; JPMorgan; and Wells Fargo are book-running managers. Quest said it will use the proceeds to fund its acquisition of the Athena Diagnostics Inc. unit of Thermo Fisher Scientific Inc. (NYSE:TMO), and to repay its outstanding senior unsecured revolving credit facility and secured receivables credit facility. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article